PROQR THERAPEUTICS NV (PRQR) Forecast, Price Target & Analyst Ratings

NASDAQ:PRQR • NL0010872495

Current stock price

1.84 USD
+0.02 (+1.1%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PROQR THERAPEUTICS NV (PRQR).

Forecast Snapshot

Consensus Price Target

Price Target
$9.18
+ 398.91% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q4 / 2025
EPS Estimate
-€0.10
Revenue Estimate
3.884M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.18
Upside
+ 398.91%
From current price of $1.84 to mean target of $9.18, Based on 15 analyst forecasts
Low
$4.04
Median
$9.18
High
$14.70

Price Target Revisions

1 Month
-6.49%
3 Months
-6.49%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for PRQR. The average price target is 9.18 USD. This implies a price increase of 398.91% is expected in the next year compared to the current price of 1.84.
The average price target has been revised downward by 6.49% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PRQR Current Analyst RatingPRQR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

PRQR Historical Analyst RatingsPRQR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.33%
PRQR was analyzed by 15 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PRQR.
In the previous month the buy percentage consensus was at a similar level.
PRQR was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-04Chardan CapitalMaintains Buy -> Buy
2025-08-08Chardan CapitalMaintains Buy -> Buy
2025-06-27Cantor FitzgeraldReiterate Overweight -> Overweight
2025-06-27JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-05-13OppenheimerMaintains Outperform -> Outperform
2025-04-29Evercore ISI GroupInitiate Outperform
2025-03-14Chardan CapitalMaintains Buy -> Buy
2025-03-14HC Wainwright & Co.Maintains Buy -> Buy
2025-02-12Jones TradingInitiate Buy
2024-12-12Chardan CapitalMaintains Buy -> Buy
2024-12-12JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-12-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-08HC Wainwright & Co.Maintains Buy -> Buy
2024-10-29Raymond JamesUpgrade Outperform -> Strong Buy
2024-05-10Chardan CapitalMaintains Buy -> Buy
2024-05-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-18CitigroupMaintains Neutral -> Neutral
2024-03-14Chardan CapitalMaintains Buy -> Buy
2024-03-14HC Wainwright & Co.Reiterate Buy -> Buy
2023-11-08Chardan CapitalUpgrade Neutral -> Buy
2023-11-08Raymond JamesMaintains Outperform -> Outperform
2023-09-18CitigroupMaintains Buy -> Buy
2023-08-07HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-04Chardan CapitalReiterate Neutral -> Neutral
2023-05-17Cantor FitzgeraldMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q4 / 2025
EPS Estimate
-€0.10
Revenue Estimate
3.884M
Revenue Q2Q
-9.82%
EPS Q2Q
-10.56%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
0.18%
Revenue (3 Months)
0.18%
EPS (1 Month)
0.00%
EPS (3 Months)
6.37%

Next Earnings Summary

PRQR is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.1 USD and the consensus revenue estimate is 3.88M USD.
The next earnings revenue estimate has been revised upward by 0.18% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PRQR revenue by date.PRQR revenue by date.
4.8M
100.00%		9.525M
98.44%		19.545M
105.20%		15.37M
-21.36%		18.205M
18.45%		13.047M
-28.33%		75.472M
478.46%		96.001M
27.20%		187.16M
94.96%		249.85M
33.50%		389.85M
56.03%		549.73M
41.01%
EBITDA
YoY % growth
PRQR ebitda by date.PRQR ebitda by date.
-62.2M
-13.38%		-29.346M
52.82%		-27.711M
5.57%		-48.246M
-74.10%		-14.484M
69.98%		-55.08M
-280.28%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
PRQR ebit by date.PRQR ebit by date.
-64.72M
-13.17%		-31.859M
50.77%		-30.472M
4.35%		-46.719M
-53.32%		-50.96M
-9.08%		-73.543M
-44.31%		-47.261M
35.74%		8.584M
118.16%		335.31M
3,806.22%		590.74M
76.18%		1.015B
71.82%		276.16M
-72.79%
Operating Margin
PRQR operating margin by date.PRQR operating margin by date.
-1,348.33%-334.48%-155.91%-303.96%-279.92%-563.68%-62.62%8.94%179.16%236.44%260.36%50.24%
EPS
YoY % growth
PRQR eps by date.PRQR eps by date.
-0.91
6.19%		-0.35
61.54%		-0.31
10.40%		-0.44
-39.17%		-0.56
-27.65%		-0.60
-7.25%		N/AN/AN/AN/AN/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.10
-10.56%		-0.12
-22.51%		-0.12
-2.77%		-0.13
-29.18%		-0.15
-48.97%
Revenue
Q2Q % growth		3.884M
-9.82%		3.916M
-13.34%		3.606M
-5.53%		3.362M
16.66%		2.81M
-27.65%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-11.409M
-13.17%		-12.138M
-12.22%		-13.641M
-11.36%		-15.039M
-33.28%		-16.44M
-44.10%

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PRQR Yearly Revenue VS EstimatesPRQR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M 500M
PRQR Yearly EPS VS EstimatesPRQR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-23.97%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-13.92%
Revenue Next 5 Year
36.24%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-16.57%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PROQR THERAPEUTICS NV / PRQR Forecast FAQ

What is the average price target for PROQR THERAPEUTICS NV (PRQR) stock?

15 analysts have analysed PRQR and the average price target is 9.18 USD. This implies a price increase of 398.91% is expected in the next year compared to the current price of 1.84.

Can you provide the upcoming earnings date for PROQR THERAPEUTICS NV?

PROQR THERAPEUTICS NV (PRQR) will report earnings on 2026-05-06.

What are the consensus estimates for PRQR stock next earnings?

The consensus EPS estimate for the next earnings of PROQR THERAPEUTICS NV (PRQR) is -0.1 USD and the consensus revenue estimate is 3.88M USD.

What is the expected long term growth rate for PRQR stock?

The expected long term growth rate for PROQR THERAPEUTICS NV (PRQR) is -13.92%.